Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR.
暂无分享,去创建一个
R. Hay | P. Coyle | G. Hogg | S. Hedderwick | R. McMullan | L. Metwally | B. Mccloskey | H. O'neill | C. Webb | G. M. Ong | G. Thompson | R. Mcmullan | Peter V. Coyle
[1] M. Farrington,et al. Candidaemia in a large teaching hospital: a clinical audit. , 2006, QJM : monthly journal of the Association of Physicians.
[2] G. Forrest,et al. Peptide Nucleic Acid Fluorescence In Situ Hybridization-Based Identification of Candida albicans and Its Impact on Mortality and Antifungal Therapy Costs , 2006, Journal of Clinical Microbiology.
[3] S. Jalal,et al. Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] K. Garey,et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] B. Alexander,et al. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. , 2006, Diagnostic microbiology and infectious disease.
[6] T. Brown,et al. DNA probes for the rapid identification of medically important Candida species using a multianalyte profiling system. , 2006, FEMS immunology and medical microbiology.
[7] T. Sorrell,et al. Simultaneous Detection and Identification of Candida, Aspergillus, and Cryptococcus Species by Reverse Line Blot Hybridization , 2006, Journal of Clinical Microbiology.
[8] M. Miyaji,et al. Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[9] B. Alexander,et al. Multicenter Evaluation of a Candida albicans Peptide Nucleic Acid Fluorescent In Situ Hybridization Probe for Characterization of Yeast Isolates from Blood Cultures , 2005, Journal of Clinical Microbiology.
[10] A. Ellepola,et al. Laboratory diagnosis of invasive candidiasis. , 2005, Journal of microbiology.
[11] A. Limaye,et al. Rapid Identification of Commonly Encountered Candida Species Directly from Blood Culture Bottles , 2003, Journal of Clinical Microbiology.
[12] M. Aoun,et al. Rapid Detection of Candida albicans in Clinical Blood Samples by Using a TaqMan-Based PCR Assay , 2003, Journal of Clinical Microbiology.
[13] P. White,et al. Detection of seven Candida species using the Light-Cycler system. , 2003, Journal of medical microbiology.
[14] R. Gaynes,et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] T. G. Mitchell,et al. Rapid Identification of Pathogenic Fungi Directly from Cultures by Using Multiplex PCR , 2002, Journal of Clinical Microbiology.
[16] B. Millar,et al. Trends in the epidemiology of Candida bloodstream infections in Northern Ireland between January 1984 and December 2000. , 2002, The Journal of infection.
[17] C. Kurtzman,et al. Fluorescence In Situ Hybridization with Peptide Nucleic Acid Probes for Rapid Identification of Candida albicans Directly from Blood Culture Bottles , 2002, Journal of Clinical Microbiology.
[18] C. Kurtzman,et al. Differentiation of Candida albicans and Candida dubliniensis by Fluorescent In Situ Hybridization with Peptide Nucleic Acid Probes , 2001, Journal of Clinical Microbiology.
[19] A. Huang,et al. Rapid Identification of Yeasts in Positive Blood Cultures by a Multiplex PCR Method , 2001, Journal of Clinical Microbiology.
[20] M. Pfaller,et al. International Surveillance of Bloodstream Infections Due toCandida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program , 2001, Journal of Clinical Microbiology.
[21] M. Wong,et al. Rapid Identification of Candida dubliniensis Using a Species-Specific Molecular Beacon , 2000, Journal of Clinical Microbiology.
[22] G. Fadda,et al. Reverse Cross Blot Hybridization Assay for Rapid Detection of PCR-Amplified DNA from Candida Species, Cryptococcus neoformans, and Saccharomyces cerevisiae in Clinical Samples , 2000, Journal of Clinical Microbiology.
[23] M. Brandt,et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. , 1999, Diagnostic microbiology and infectious disease.
[24] F. Nolte,et al. Rapid Identification of up to ThreeCandida Species in a Single Reaction Tube by a 5′ Exonuclease Assay Using Fluorescent DNA Probes , 1999, Journal of Clinical Microbiology.
[25] T. Lott,et al. Rapid Identification of Candida Species with Species-Specific DNA Probes , 1998, Journal of Clinical Microbiology.
[26] D. Relman,et al. Improved Amplification of Microbial DNA from Blood Cultures by Removal of the PCR Inhibitor Sodium Polyanetholesulfonate , 1998, Journal of Clinical Microbiology.
[27] G. Roberts,et al. Comparison of RapID Yeast Plus System with API 20C System for Identification of Common, New, and Emerging Yeast Pathogens , 1998, Journal of Clinical Microbiology.
[28] F. Nolte,et al. Rapid identification of Candida species in blood cultures by a clinically useful PCR method , 1997, Journal of clinical microbiology.
[29] H. Einsele,et al. Detection and identification of fungal pathogens in blood by using molecular probes , 1997, Journal of clinical microbiology.
[30] G. Fadda,et al. Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis , 1997, Journal of clinical microbiology.
[31] S. Fridkin,et al. Epidemiology of nosocomial fungal infections , 1996, Clinical microbiology reviews.
[32] M. Pfaller. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] T. Lott,et al. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood , 1995, Journal of clinical microbiology.
[34] M. Beckius,et al. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card , 1994, Journal of clinical microbiology.
[35] M. Levenstein,et al. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia , 1994 .
[36] C. Beck-Sague,et al. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.
[37] R F Woolson,et al. Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.